US Vice-President Kamala Harris tests positive for Covid-19
Darpan News Desk IANS, 26 Apr, 2022 12:57 PM
Washington, April 26 (IANS) US Vice President Kamala Harris tested positive for Covid-19 on undergoing rapid and PCR tests, her spokesperson said.
Today I tested positive for COVID-19. I have no symptoms, and I will continue to isolate and follow CDC guidelines. I’m grateful to be both vaccinated and boosted.
"She has exhibited no symptoms, will isolate and continue to work from the Vice President's residence," the spokesperson added on Tuesday in a statement.
Harris, 57, has not been a close contact to US President Joe Biden or the first lady "due to their respective recent travel schedules," the statement said.
The statement added that the Vice-President will follow Centers for Disease Control and Prevention guidelines and the advice of her physicians and will return to the White House when she tests negative, Xinhua news agency reported.
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws.
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.
